Clinical Trials-Kore Liow, MD, FACP, FAAN, CPI Lacosamide
Of Brivaracetam used as adjunctive
Maximum of 150mg/day in epilepsy subjects 16 years or older.
Evaluate Previously Developed Shape Classification Algorithm Procedures (CAP) Using MRI to Accurately Discriminate Between Schizophrenic Patients And Normal Controls
Study of Rufinamide Given
And Tolerability of Adjunctive LEP105972
LTG-XR in Elderly Subjects Generic Antiepileptic Drug Generic Antiepileptic Drug
Conversion to Lacosamide
Study of Rufinamide Given as Adjunctive Therapy in Patients with refractory Partial Seizures
An International, double-blind UCB N01199
Brivaracetam in subjects
Investigation of Hypnosis In
Seizure Provocation and Differentiation Between Epileptic And Non-Epileptic Seizure Events
Tolerability of Carisbamate as Adjunctive therapy in patients
Followed by an Open-Label Extension Study.
Historical control, randomized Study # N01289
Study with KEPPRA XR for
Reducing Health Disparities NIH LRP Award CDC MM-1002-07/07
and Prevalence of Epilepsy
Clinical and Neurogenetics
Submission to the NINDS Quality of Life Measurements in Elderly with Epilepsy
Assess the Safety and to Demonstrate that the Responsive Neurostimulator (RNS) System is as Effective as an Adjunctive Therapy in Reducing Seizures in Individuals over 18 Years Old or older With Partial Onset Seizures That are Refractory to Two or more Antiepileptic Medications.
Tolerability and Efficacy of GW273225 Add-on Treatment of Partial Seizures, Whether or Not Secondarily Generalized.
of Monotherapy Topiramate versus Protocol CAPSS-272 Phenytoin in Subjects with Seizures TIME (Topamax Initiated as
Effectiveness and Safety of Topamax RWJ-17021-000, as Monotherapy in the Treatment of Epilepsy in Clinical Practice.
(Antiepileptic Drugs) on Bone Density.
To Investigate the Effect of “Brain Cooling” on the Interictal Epileptiform SRTP Award Activities Recorded during Epilepsy Surgery.
risk/benefits of antiepileptic drugs in the treatment of women with epilepsy in terms of their neurobehavioral development after in-utero exposure. NIH NEAD II
Assessment of Prevalence of Obesity U Kansas
and Physical Inactivity In Epilepsy Patients
study examining the safety, tolerability and efficacy of UCB 44212 (Seletraracetam) used at doses of 10,20,40 and 80 mg bid. (total daily doses of 20-160mg) administration (oral capsules) in adult subjects (18-65 years) with refractory epilepsy suffering from partial onset seizures who are currently taking Levetiracetam but still experiencing seizures. ERSET (Early Randomized
Multicenter Randomized controlled trial to compare the efficacy of early surgical intervention for mesial temporal lobe epilepsy with continued optimal pharmacotherapy.
to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects with Refractory Partial Seizures.
Tolerability of IV SPM 927 as a Replacement for Oral SPM 927 in Subjects with Partial Seizures with or without Secondary Generalization.
Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Partial Seizures.
about Stigma, Education, and Awareness: Preliminary Responses Based on a Community Participatory Approach
Tolerability and Efficacy Of long term oral SPM 927 Lamotrigine and Leviteracetam
Efficacy of Long Term Oral SPM 927 in Patients with Partial Seizures., Vagal Nerve Stimulator
Randomized, Placebo-controlled, SP 754 Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization.
Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures. Stigma and Safe Havens: U Kansas
Efficacy Of Long Term Oral SPM 927 As Adjunctive Therapy In Patients With Partial Seizures. Vagal Nerve Stimulator
Parameter Study, Comparison Protocol # VCRI-06-227 of Two Stimulation Settings for the Vagal Nerve Stimulators Used for Treatment of Epilepsy,
controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization
Of Patients using VNS to Patients NINDS, NIH
Baade, Stembridge (Neurodevelopment Effects NS 38455,
of Antiepileptic Drugs) Multicenter study to investigate the relative risk/benefits of antiepileptic drugs on the behavior and cognition of children born to mothers with epilepsy after in-utero exposure. http://spitfire.emmes.com/study/nead/
Behavior and Daily Living Skills in Cognitively Challenged Refractory Epilepsy Patients Using VNS Lamotrigine Adjunctive
Therapy in Primarily Generalized Seizures
NIH-NINDS TMS (Transcranial Magnetic Intramural Stimulation) for Refractory Melatonin on the Activities of Protocol 00-CC-0015 Cytochrome p 450 1A2, 2D6, 3A4, N-acetyltransferase-2 (NAT2), and Xanthine Oxidase (XO),
The Effect of Vigabatrin on
Problemskapande beteenden - Leif Ekström Efter en välbehövlig kafferast och bensträckarpaus var det dags att lyssna till Leif Ekström som talade om problemskapande beteenden. Han presenterade sig som en mångårig medarbetare inom habiliteringen, som nu gått i pension. – Halva yrkeslivet har jag arbetat som speciallärare i grundskolan och halva yrkeslivet har jag ägnat åt autis
Walter D’Alessio receives Magee Rehabilitation’s 2003 Humanitarian Award Walter D’Alessio, Chairman and Chief Executive Officer of LeggMason Real Estate Services, was presented with Magee’sHumanitarian Award at the Hospital’s 16th Annual HumanitarianAward Dinner on November 18, at the Four Seasons Hotel. Mr. D’Alessio was honored for his career-long efforts in improvingthe lives